Skip to main content
Opens in new window
NHS Wales
NHS 111 Wales
Skip Navigation
Accessibility
Contact us
Cymraeg
Cymraeg
All...
Search
All Wales Therapeutics and Toxicology Centre
Search
Cymraeg
Cymraeg
Menu
Home
Accessing medicines
Show Submenu For Accessing medicines
Medicine recommendations
Access to medicines in Wales
Make a submission
Medicines optimisation and safety
Show Submenu For Medicines optimisation and safety
Medicines optimisation guidance, resources and data
Yellow Card Centre Wales
Welsh National Poisons Unit
Work in progress
News, meetings and events
Show Submenu For News, meetings and events
News
Meetings
Events
About us
Show Submenu For About us
Who we are
What we do
Our committees
Who we work with
Our research
Our reports and strategies
Sustainability
Contact us
More
×
NHS Wales
NHS 111 Wales
Accessibility
Contact us
All...
Search
Listen
Home
›
Files
›
SOAs
SOAs
17/02/2020
Statement of Advice (SOA): bevacizumab (Avastin) 1824
17/02/2020
Statement of Advice (SOA): bevacizumab (Avastin) 3165
17/02/2020
Statement of Advice (SOA): bezlotoxumab (Zinplava) 3034
17/02/2020
Statement of Advice (SOA): bilastine (llaxten) 1068
17/02/2020
Statement of Advice (SOA): bimato prost timolol (Ganfort) 2370
17/02/2020
Statement of Advice (SOA): Apalutamide (Erleada) 2450
17/02/2020
Statement of Advice (SOA): bismuth metronidazolete tracycline (Pylera)1544
18/02/2020
Statement of Advice (SOA): brentuximab vedotin (Adcetris) 2074
18/02/2020
Statement of Advice (SOA): bosentan (Tracleer) 68
18/02/2020
Statement of Advice (SOA): bosentan (Tracleer) 67
18/02/2020
Statement of Advice (SOA): bosutinib (Bosulif) 2507
18/02/2020
Statement of Advice (SOA): botulinum toxin type A (Botox) 2540
18/02/2020
Statement of Advice (SOA): botulinum toxin type A (Botox) 1845
18/02/2020
Statement of Advice (SOA): Brentuximab vedotin (Adcetris) 2074
18/02/2020
Statement of Advice (SOA): brexpiprazole (Rexulti) 1372
18/02/2020
Statement of Advice (SOA): bosentan (Tracleer) 68
12/02/2020
Statement of Advice (SOA): alendronic acid (Steovess) 1612
12/02/2020
Statement of Advice (SOA): allopurinol lesinurad (Duzallo) 3588
12/02/2020
Statement of Advice (SOA): alipogene tiparvovec (Glybera) 645
12/02/2020
Statement of Advice (SOA): alogliptin pioglitazone (Incresync) 1272
1
2
3
4
5
6
7
8
9
10
11
Follow AWTTC: